Ovid Therapeutics Inc
F:1OT
Ovid Therapeutics Inc
F:1OT
Price:
1.99
EUR
5.29%
Market Closed
Market Cap:
€140.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
Ovid Therapeutics Inc
F:1OT
|
US |
|
G
|
Ghani Glass Ltd
KAR:GHGL
|
PK |
|
G
|
Gilat Satellite Networks Ltd
F:GSA
|
IL |
|
O
|
Orora Ltd
OTC:ORRYY
|
AU |
|
Picpay Holdings Netherlands BV
NASDAQ:PICS
|
BR |
|
Cellularline SpA
MIL:CELL
|
IT |
|
F
|
Federal Agricultural Mortgage Corp
F:A35
|
US |
|
G
|
Ghani Chemical Industries Ltd
KAR:GCIL
|
PK |
Wall St Price Targets
1OT Price Targets Summary
Ovid Therapeutics Inc
Ovid Therapeutics Inc
Wall Street analysts forecast 1OT stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 1OT is 3.29 EUR with a low forecast of 2.37 EUR and a high forecast of 4.3 EUR.
Lowest Forecast
Price Target
2.37
EUR
19% Upside
Average Forecast
Price Target
3.29
EUR
65% Upside
Highest Forecast
Price Target
4.3
EUR
116% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1OT's stock price target?
Price Target
3.29
EUR
3.29
EUR
According to Wall Street analysts, the average 1-year price target for 1OT is 3.29 EUR with a low forecast of 2.37 EUR and a high forecast of 4.3 EUR.
What is the Revenue forecast for Ovid Therapeutics Inc?
Projected CAGR
76%
76%
The compound annual growth rate for Revenue over the next 8 years is 76%.
